FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055142209> ?p ?o ?g. }

• W2055142209 endingPage "1138" @default.
• W2055142209 startingPage "1131" @default.
• W2055142209 abstract "Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.BackgroundDiabetic nephropathy is the leading cause of end-stage renal disease (ESRD). Anemia is common in diabetics with nephropathy; however, the impact of anemia on progression to ESRD has not been carefully examined.MethodsWe studied the relationship between baseline hemoglobin concentration (Hb) and progression of diabetic nephropathy to ESRD in 1513 participants enrolled in Reduction in Endpoints in NIDDM with the Angiotensin II Antagonist Losartan study and followed for an average of 3.4 years. Multivariate Cox proportional hazards models were used to analyze the relationship between Hb and ESRD, after adjusting for predictors for ESRD. Analyses were performed with Hb stratified by quartile: first quartile <11.3 g/dL, second quartile 11.3 to 12.5 g/dL, third quartile 12.6 to 13.8 g/dL, and fourth quartile ≥13.8 g/dL (reference) and as a continuous variable.ResultsBaseline hemoglobin concentration was correlated with subsequent development of ESRD. After adjustment for predictors of ESRD, the hazard ratios for the first, second, and third Hb quartiles were 1.99 (95% CI, 1.34-2.95), 1.61 (95% CI 1.08-2.41), and 1.87 (95% CI 1.25-2.80). With hemoglobin as a continuous variable, the adjusted hazard ratio was 0.90 (95% CI 0.84-0.96, P = 0.0013). The average increase in adjusted relative risk was 11% for each 1 g/dL decrease in hemoglobin concentration.ConclusionOur data suggest that even mild anemia, Hb <13.8 g/dL increases risk for progression to ESRD. Hemoglobin is an independent risk factor for progression of nephropathy to ESRD in type 2 diabetes. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). Anemia is common in diabetics with nephropathy; however, the impact of anemia on progression to ESRD has not been carefully examined. We studied the relationship between baseline hemoglobin concentration (Hb) and progression of diabetic nephropathy to ESRD in 1513 participants enrolled in Reduction in Endpoints in NIDDM with the Angiotensin II Antagonist Losartan study and followed for an average of 3.4 years. Multivariate Cox proportional hazards models were used to analyze the relationship between Hb and ESRD, after adjusting for predictors for ESRD. Analyses were performed with Hb stratified by quartile: first quartile <11.3 g/dL, second quartile 11.3 to 12.5 g/dL, third quartile 12.6 to 13.8 g/dL, and fourth quartile ≥13.8 g/dL (reference) and as a continuous variable. Baseline hemoglobin concentration was correlated with subsequent development of ESRD. After adjustment for predictors of ESRD, the hazard ratios for the first, second, and third Hb quartiles were 1.99 (95% CI, 1.34-2.95), 1.61 (95% CI 1.08-2.41), and 1.87 (95% CI 1.25-2.80). With hemoglobin as a continuous variable, the adjusted hazard ratio was 0.90 (95% CI 0.84-0.96, P = 0.0013). The average increase in adjusted relative risk was 11% for each 1 g/dL decrease in hemoglobin concentration. Our data suggest that even mild anemia, Hb <13.8 g/dL increases risk for progression to ESRD. Hemoglobin is an independent risk factor for progression of nephropathy to ESRD in type 2 diabetes." @default.
• W2055142209 created "2016-06-24" @default.
• W2055142209 creator A5003493851 @default.
• W2055142209 creator A5004435991 @default.
• W2055142209 creator A5008309890 @default.
• W2055142209 creator A5016263167 @default.
• W2055142209 creator A5046420696 @default.
• W2055142209 creator A5052126717 @default.
• W2055142209 date "2004-09-01" @default.
• W2055142209 modified "2023-10-16" @default.
• W2055142209 title "Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy" @default.
• W2055142209 cites W1964794067 @default.
• W2055142209 cites W1968206105 @default.
• W2055142209 cites W1968668632 @default.
• W2055142209 cites W1980338884 @default.
• W2055142209 cites W1983269730 @default.
• W2055142209 cites W1984219766 @default.
• W2055142209 cites W1985941010 @default.
• W2055142209 cites W1987189111 @default.
• W2055142209 cites W2018901137 @default.
• W2055142209 cites W2022455072 @default.
• W2055142209 cites W2032142805 @default.
• W2055142209 cites W2055534323 @default.
• W2055142209 cites W2056976690 @default.
• W2055142209 cites W2059346848 @default.
• W2055142209 cites W2060380118 @default.
• W2055142209 cites W2067988311 @default.
• W2055142209 cites W2068697451 @default.
• W2055142209 cites W2071729123 @default.
• W2055142209 cites W2081413391 @default.
• W2055142209 cites W2082263332 @default.
• W2055142209 cites W2083403848 @default.
• W2055142209 cites W2104416692 @default.
• W2055142209 cites W2111478351 @default.
• W2055142209 cites W2117418442 @default.
• W2055142209 cites W2135705997 @default.
• W2055142209 cites W2140623175 @default.
• W2055142209 cites W2141869043 @default.
• W2055142209 cites W2151617426 @default.
• W2055142209 cites W2157119745 @default.
• W2055142209 cites W2163013875 @default.
• W2055142209 cites W2169632325 @default.
• W2055142209 cites W2213612481 @default.
• W2055142209 cites W2264909951 @default.
• W2055142209 cites W2623950815 @default.
• W2055142209 cites W3025393355 @default.
• W2055142209 cites W4252437054 @default.
• W2055142209 doi "https://doi.org/10.1111/j.1523-1755.2004.00863.x" @default.
• W2055142209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15327408" @default.
• W2055142209 hasPublicationYear "2004" @default.
• W2055142209 type Work @default.
• W2055142209 sameAs 2055142209 @default.
• W2055142209 citedByCount "187" @default.
• W2055142209 countsByYear W20551422092012 @default.
• W2055142209 countsByYear W20551422092013 @default.
• W2055142209 countsByYear W20551422092014 @default.
• W2055142209 countsByYear W20551422092015 @default.
• W2055142209 countsByYear W20551422092016 @default.
• W2055142209 countsByYear W20551422092017 @default.
• W2055142209 countsByYear W20551422092018 @default.
• W2055142209 countsByYear W20551422092019 @default.
• W2055142209 countsByYear W20551422092020 @default.
• W2055142209 countsByYear W20551422092021 @default.
• W2055142209 countsByYear W20551422092022 @default.
• W2055142209 countsByYear W20551422092023 @default.
• W2055142209 crossrefType "journal-article" @default.
• W2055142209 hasAuthorship W2055142209A5003493851 @default.
• W2055142209 hasAuthorship W2055142209A5004435991 @default.
• W2055142209 hasAuthorship W2055142209A5008309890 @default.
• W2055142209 hasAuthorship W2055142209A5016263167 @default.
• W2055142209 hasAuthorship W2055142209A5046420696 @default.
• W2055142209 hasAuthorship W2055142209A5052126717 @default.
• W2055142209 hasBestOaLocation W20551422091 @default.
• W2055142209 hasConcept C126322002 @default.
• W2055142209 hasConcept C126894567 @default.
• W2055142209 hasConcept C134018914 @default.
• W2055142209 hasConcept C207103383 @default.
• W2055142209 hasConcept C2777180221 @default.
• W2055142209 hasConcept C2778248108 @default.
• W2055142209 hasConcept C2778653478 @default.
• W2055142209 hasConcept C2778917026 @default.
• W2055142209 hasConcept C2779134260 @default.
• W2055142209 hasConcept C2779922275 @default.
• W2055142209 hasConcept C2780091579 @default.
• W2055142209 hasConcept C2780288358 @default.
• W2055142209 hasConcept C2781184683 @default.
• W2055142209 hasConcept C2908929049 @default.
• W2055142209 hasConcept C3019040382 @default.
• W2055142209 hasConcept C44249647 @default.
• W2055142209 hasConcept C50382708 @default.
• W2055142209 hasConcept C555293320 @default.
• W2055142209 hasConcept C68443243 @default.
• W2055142209 hasConcept C71924100 @default.
• W2055142209 hasConcept C84393581 @default.
• W2055142209 hasConcept C90924648 @default.
• W2055142209 hasConceptScore W2055142209C126322002 @default.
• W2055142209 hasConceptScore W2055142209C126894567 @default.
• W2055142209 hasConceptScore W2055142209C134018914 @default.

• next